![FDA Approves Foundation Medicine's FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics | Business Wire FDA Approves Foundation Medicine's FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics | Business Wire](https://mms.businesswire.com/media/20171130006320/en/627349/5/FMI_Exterior_for_Press_Kit.jpg)
FDA Approves Foundation Medicine's FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics | Business Wire
![Roche France, Foundation Medicine and the Institute Gustave Roussy announce unique partnership to provide in-house liquid biopsy genomic testing to cancer patients in France | Gustave Roussy Roche France, Foundation Medicine and the Institute Gustave Roussy announce unique partnership to provide in-house liquid biopsy genomic testing to cancer patients in France | Gustave Roussy](https://www.gustaveroussy.fr/sites/default/files/cppartenariat-fresh-share-180923.png)
Roche France, Foundation Medicine and the Institute Gustave Roussy announce unique partnership to provide in-house liquid biopsy genomic testing to cancer patients in France | Gustave Roussy
![Foundation Medicine Announces Strategic Collaboration with Major Pharmaceutical Company | Business Wire Foundation Medicine Announces Strategic Collaboration with Major Pharmaceutical Company | Business Wire](https://mms.businesswire.com/media/20181017005105/en/627351/23/FMI_lockup%C2%AE_left_fire_RGB300ppi_For_BW.jpg)